Interv Akut Kardiol. 2022;21(3):132-138 | DOI: 10.36290/kar.2022.016

Near infrared spectroscopy (NIRS) - method in retreat or rising star?

Martin Hudec1, 2, Jan Kaňovský1, 2, Ivona Kask1, Kristýna Hlaváčová1, Vojtěch Brázdil1, 2, Petr Kala1, 2
1 Interní kardiologická klinika Fakultní nemocnice Brno
2 Lékařská fakulta Masarykovy univerzity Brno

The development of interventional cardiology has been going on for more than 50 years. During this time, great progress has been made not only in the materials used, but also in intravascular imaging (IVI). IVI plays a key role in the identification of vulnerable plaques (VP). The methods established and used in common clinical practice are mainly optical coherence tomography (OCT) and intravascular ultrasound (IVUS). NIRS (near infrared spectroscopy) is a modern method based on spectral analysis that evaluates the chemical composition of an artery. It can be used in identification of VP, the prediction of periprocedural infarctions, evaluation of the effect of hypolipidemic therapy or sizing of the implanted stent. Using combination of these methods, we obtain a morphologic and chemical analysis of atherosclerotic plaques. In the future, it could provide complete information about the evaluated coronary system. This could be the basis for determining the vulnerability of individual plaques and thus optimizing the therapy.

Keywords: NIRS, near infrared spectroscopy, intracoronary imaging.

Received: March 15, 2022; Revised: April 17, 2022; Accepted: May 2, 2022; Prepublished online: May 2, 2022; Published: November 21, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hudec M, Kaňovský J, Kask I, Hlaváčová K, Brázdil V, Kala P. Near infrared spectroscopy (NIRS) - method in retreat or rising star? Interv Akut Kardiol. 2022;21(3):132-138. doi: 10.36290/kar.2022.016.
Download citation

References

  1. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the Vulnerable Plaque. J Am Coll Cardiol. 2006;47(8):C13-C18. doi:10.1016/j.jacc.2005. 10. 065. Go to original source...
  2. Higuma T, Soeda T, Abe N, et al. A Combined Optical Coherence Tomography and Intravascular Ultrasound Study on Plaque Rupture, Plaque Erosion, and Calcified Nodule in Patients With ST­‑Segment Elevation Myocardial Infarction. JACC Cardiovasc Interv. 2015;8(9):1166-1176. doi:10.1016/j.jcin.2015. 02. 026 Go to original source... Go to PubMed...
  3. Červinka P, Špaček R, Kala P. Optická koherentní tomografie. Interv Akut Kardiol. 2011;10 (Suppl.D):21-23.
  4. Nováková T, Kala P, Prýmková L, Kaňovský J. Využití optické koherentní tomografie (OCT) u akutního koronárního syndromu. Interv Akut Kardiol 2019;18(1): 28-31. doi: 10.36290/kar.2018.019. Go to original source...
  5. Garcìa­‑Garcìa HM, Gogas BD, Serruys PW, Bruining N. IVUS­‑based imaging modalities for tissue characterization: similarities and differences. Int J Cardiovasc Imaging. 2011;27(2): 215-224. doi:10.1007/s10554-010-9789-7. Go to original source... Go to PubMed...
  6. Gardner CM, Tan H, Hull EL, et al. Detection of Lipid Core Coronary Plaques in Autopsy Specimens With a Novel Catheter­‑Based Near­‑Infrared Spectroscopy System. JACC Cardiovasc Imaging. 2008;1(5):638-648. doi:10.1016/j.jcmg.2008. 06. 001. Go to original source... Go to PubMed...
  7. Waxman S, Dixon SR, L'Allier P, et al. In Vivo Validation of a Catheter­‑Based Near­‑Infrared Spectroscopy System for Detection of Lipid Core Coronary Plaques. JACC Cardiovasc Imaging. 2009;2(7):858-868. doi:10.1016/j.jcmg.2009. 05. 001. Go to original source... Go to PubMed...
  8. Negi SI, Didier R, Ota H, et al. Role of near­‑infrared spectroscopy in intravascular coronary imaging. Cardiovasc Revasc Med. 2015;16(5):299-305. doi:10.1016/j.carrev.2015. 06. 001. Go to original source... Go to PubMed...
  9. Neumann FJ, Sousa­‑Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87-165. doi:10.1093/eurheartj/ehy394. Go to original source... Go to PubMed...
  10. Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST­‑segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST­‑segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2021;42(14):1289-1367. doi:10.1093/eurheartj/ehaa575 Go to original source... Go to PubMed...
  11. Gributs CEW, Burns DH. In Vivo Near­‑Infrared Spectrometry. In: Chalmers JM, Griffiths PR, eds. Handbook of Vibrational Spectroscopy. John Wiley & Sons, Ltd; 2006:s8108. doi:10.1002/0470027320.s8108. Go to original source...
  12. Kilic ID, Caiazzo G, Fabris E, et al. Near­‑infrared spectroscopy­‑intravascular ultrasound: scientific basis and clinical applications. Eur Heart J - Cardiovasc Imaging. Published online September 20, 2015:jev208. doi:10.1093/ehjci/jev208. Go to original source... Go to PubMed...
  13. Moreno PR, Lodder RA, Purushothaman KR, et al. Detection of Lipid Pool, Thin Fibrous Cap, and Inflammatory Cells in Human Aortic Atherosclerotic Plaques by Near­‑Infrared Spectroscopy. Circulation. 2002;105(8):923-927. doi:10.1161/hc0802.104291. Go to original source... Go to PubMed...
  14. Kuku KO, Singh M, Ozaki Y, et al. Near­‑Infrared Spectroscopy Intravascular Ultrasound Imaging: State of the Art. Front Cardiovasc Med. 2020;7. doi:10.3389/fcvm.2020.00107 Go to original source... Go to PubMed...
  15. Swamy PM, Mamas MA, Bharadwaj AS. Role of Near­‑Infrared Spectroscopy (NIRS) in Intracoronary Imaging. Curr Cardiovasc Imaging Rep. 2019;12(8):34. doi:10.1007/s12410-019-9510-8. Go to original source...
  16. Horváth M, Hájek P, Štěchovský C, et al. Vulnerable plaque imaging and acute coronary syndrome. Cor Vasa. 2014;56(4):e362-e368. doi:10.1016/j.crvasa.2014. 05. 002. Go to original source...
  17. Jaffe R, Charron T, Puley G, et al. Microvascular Obstruction and the No­‑Reflow Phenomenon After Percutaneous Coronary Intervention. Circulation. 2008;117(24):3152-3156. doi:10.1161/CIRCULATIONAHA.107.742312. Go to original source... Go to PubMed...
  18. Goldstein JA, Maini B, Dixon SR, et al. Detection of Lipid­‑Core Plaques by Intracoronary Near­‑Infrared Spectroscopy Identifies High Risk of Periprocedural Myocardial Infarction. Circ Cardiovasc Interv. 2011;4(5):429-437. doi:10.1161/CIRCINTERVENTIONS.111.963264. Go to original source... Go to PubMed...
  19. Stone GW, Maehara A, Muller JE, et al. Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2015;8(7):927-936. doi:10.1016/j.jcin.2015. 01. 032. Go to original source... Go to PubMed...
  20. Kini AS, Baber U, Kovacic JC, et al. Changes in Plaque Lipid Content After Short­‑Term Intensive Versus Standard Statin Therapy. J Am Coll Cardiol. 2013;62(1):21-29. doi:10.1016/j.jacc.2013. 03. 058. Go to original source...
  21. Kini AS, Vengrenyuk Y, Shameer K, et al. Intracoronary Imaging, Cholesterol Efflux, and Transcriptomes After Intensive Statin Treatment. J Am Coll Cardiol. 2017;69(6):628-640. doi:10.1016/j.jacc.2016. 10. 029. Go to original source...
  22. University Hospital Inselspital, Berne. Effects of the PCSK9 Antibody AliroCuMab on Coronary Atherosclerosis in PatieNts With Acute Myocardial Infarction: A Serial, Multivessel, Intravascular Ultrasound, Near­‑Infrared Spectroscopy And Optical Coherence Tomography Imaging Study. clinicaltrials.gov; 2020. Accessed March 24, 2021. https://clinicaltrials.gov/ct2/show/NCT03067844.
  23. Radboud University. Functional Improvement of Non­‑InfarcT RelaTed Coronary Artery Stenosis by Extensive LDL­‑C Reduction With a PCSK9 Antibody. clinicaltrials.gov; 2020. Accessed March 24, 2021. https://clinicaltrials.gov/ct2/show/NCT04141579.
  24. Dixon SR, Grines CL, Munir A, et al. Analysis of Target Lesion Length Before Coronary Artery Stenting Using Angiography and Near­‑Infrared Spectroscopy Versus Angiography Alone. Am J Cardiol. 2012;109(1):60-66. doi:10.1016/j.amjcard.2011. 07. 068. Go to original source...
  25. Stone GW, Maehara A, Lansky AJ, et al. A Prospective Natural­‑History Study of Coronary Atherosclerosis. N Engl J Med. 2011;364(3):226-235. doi:10.1056/NEJMoa1002358. Go to original source... Go to PubMed...
  26. Oemrawsingh RM, Cheng JM, García­‑García HM, et al. Near­‑Infrared Spectroscopy Predicts Cardiovascular Outcome in Patients With Coronary Artery Disease. J Am Coll Cardiol. 2014;64(23):2510-2518. doi:10.1016/j.jacc.2014. 07. 998. Go to original source...
  27. Waksman R, Di Mario C, Torguson R, et al. Identification of patients and plaques vulnerable to future coronary events with near­‑infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study. The Lancet. 2019;394(10209): 1629-1637. doi:10.1016/S0140-6736(19)31794-5. Go to original source... Go to PubMed...
  28. Erlinge D, Maehara A, Ben­‑Yehuda O, et al. Identification of vulnerable plaques and patients by intracoronary near­‑infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study. The Lancet. 2021;397(10278):985-995. doi:10.1016/S0140-6736(21)00249-X. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.